The CEO said the most impressive aspect of the trial vis-à-vis hypoglycemia was that the bedtime oral dose, which was not followed by food, caused no noted hypoglycemia events. The obvious question is how many events were not noted.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”